Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Thomas Lamb

Snake Bite Coordinator

Thomas Lamb is a project coordinator for antivenom research at MOCRU and the 1st Hamish Ogston Foundation Fellow. His prior clinical experience with snake-bite envenoming in India, Bangladesh and UK has resulted in a desire to improve antivenom availability and affordability to those who need it most in a timely manner.

Snake bite in Myanmar is the leading cause of acute kidney injury requiring dialysis and is estimated to cause 1,250 death/year. The principal objective of this work is to conduct a dose-finding study of a novel lyophilized Daboia siamensis antivenom produced in Myanmar. The optimal dose will seek to reverse the effects of venom in a single dose whilst limiting the incidence of severe adverse reactions. In addition to the dose-finding trial, we plan to investigate snake-bite diagnostics including the 20-minute whole blood clotting test, perform a pharmacokinetic assessment of venom in humans and describe the Daboia siamensis envenoming sequelae.